EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Sorafenib enhances graft-versus-leukemia activity through IL-18-mediated macrophage and NK cell crosstalk in FLT3-ITD acute myeloid leukemia

Ruoyang Shao, Peiru Chi, Zhiping Fan, Yuxin Bai, Zhonghui Jiang, Fang Dai, Tian Zhang, Guo Qiu, Fen Huang, Na Xu, Xiaofeng Yang, Kejing Li und 7 weitere

Cell Reports · 2026-10 · 45 (10) · 118083

DOI: 10.1016/j.celrep.2026.118083 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Reports, 2026-10. Verfasst von Ruoyang Shao und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China; Clinical Medical Research Center of Hematology Dise…. Hauptthemen laut MEDLINE: Sorafenib, Macrophages, Leukemia, Myeloid, Acute, Killer Cells, Natural. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Key Technologies Research and Development Program, National Natural Science Foundation of China, Guangdong Provincial Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SorafenibMacrophagesLeukemia, Myeloid, AcuteKiller Cells, Naturalfms-Like Tyrosine Kinase 3Graft vs Leukemia EffectInterleukin-18HumansAnimalsMiceHematopoietic Stem Cell TransplantationMice, Inbred C57BL

Stichwörter der Autor:innen

AMLCP: cancerCP: immunologyFLT3 inhibitorFLT3-ITDacute myeloid leukemiaallo-HSCTallogeneic hematopoietic stem cell transplantationmacrophagesorafenib

Substanzen

Sorafenibfms-Like Tyrosine Kinase 3Interleukin-18FLT3 protein, human

Autor:innen und Institutionen

  • Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China; Clinical Medical Research Center of Hematology Diseases of Guangdong Province, Guangzhou 510515, China.
  • Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China; Clinical Medical Research Center of Hematology Diseases of Guangdong Province, Guangzhou 510515, China. Electronic addres…
  • Department of Hematology, Peking University People's Hospital, Beijing 100044, China. Electronic address: ywyw3172@sina.com.

Förderung

  • Key Technologies Research and Development Program
  • National Natural Science Foundation of China
  • Guangdong Provincial Natural Science Foundation
  • China Postdoctoral Science Foundation

Zitieren

APA

Shao, R., Chi, P., Fan, Z., Bai, Y., Jiang, Z., Dai, F., Zhang, T., Qiu, G., Huang, F., Xu, N., Yang, X., Li, K., Zhong, Y., Jin, H., Sun, J., Xu, X., Wang, Y., Liu, Q., & Xuan, L. (2026). Sorafenib enhances graft-versus-leukemia activity through IL-18-mediated macrophage and NK cell crosstalk in FLT3-ITD acute myeloid leukemia. Cell Reports, 45(10), 118083. https://doi.org/10.1016/j.celrep.2026.118083

Vancouver

Shao R, Chi P, Fan Z, Bai Y, Jiang Z, Dai F, et al. Sorafenib enhances graft-versus-leukemia activity through IL-18-mediated macrophage and NK cell crosstalk in FLT3-ITD acute myeloid leukemia. Cell Reports. 2026;45(10):118083. doi:10.1016/j.celrep.2026.118083

BibTeX
@article{Shao2026,
  author = {Shao, Ruoyang and Chi, Peiru and Fan, Zhiping and Bai, Yuxin and Jiang, Zhonghui and Dai, Fang and Zhang, Tian and Qiu, Guo and Huang, Fen and Xu, Na and Yang, Xiaofeng and Li, Kejing and Zhong, Yueyang and Jin, Hua and Sun, Jing and Xu, Xi and Wang, Yu and Liu, Qifa and Xuan, Li},
  title = {Sorafenib enhances graft-versus-leukemia activity through IL-18-mediated macrophage and NK cell crosstalk in FLT3-ITD acute myeloid leukemia},
  journal = {Cell Reports},
  year = {2026},
  volume = {45},
  number = {10},
  pages = {118083},
  doi = {10.1016/j.celrep.2026.118083}
}
Kostenlos starten →